Class I and class II HLA genes encode major histocompatibility complex (MHC) proteins which allow for presentation of antigenic peptides such as tumor antigens to CD8+ and CD4+ T-cell lymphocytes, respectively. The gene discussed is HLA-C; the disease is neoplasm.